OFIX (Orthofix International) Market Value to Book Value Ratio

Orthofix International (OFIX) - corporate logo

The market dynamics of Orthofix Medical Inc. (OFIX), a manufacturer of specialized implants, correlate with the volume of scheduled spinal surgeries and the synergies following the SeaSpine transaction, reaching 0.93. High-precision robotics in production facilities minimize errors, although the implementation of these systems requires qualified experts. Meanwhile, stringent GPO tenders limit pricing power, meaning profit growth is driven exclusively by the introduction of new patented developments.

Market Capitalization to Net Assets: Orthofix Corp (OFIX) for 07/04/2022 - 10/27/2026
Finished products of Orthofix Medical

Investors must evaluate the market status of Orthofix Medical Inc. (OFIX), whose unique integration of implants and tissue stimulators creates an irreplaceable treatment cycle. This indicator, calculated as the ratio of market value to net assets, measures the premium for the business model, while a history of market value significantly exceeding book value allows for the identification of consolidation phases and the avoidance of false buy signals.

Direct competitors

Market Cap to Net Assets Ratio Boston Scientific|EW (edwards.com) - Capitalization to Book Value Ratio|RMD: Market Value to Book Value Ratio|Market Capitalization to Book Value PODD|ZBH - Market Value to Book Value Ratio|Market Capitalization to Net Assets CooperSurgical (COO)|ALGN: Market Capitalization to Book Value Ratio|Market-to-Book Ratio globusmedical.com GMED|TMDX: Market Capitalization to Book Value Ratio|ATEC - Market Cap to Net Assets Ratio|Artivion Inc - Market Capitalization to Book Value Ratio|Enovis Inc. (ENOV) - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ESTA|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRADIMED Corp (IRMD)|Market Capitalization to Book Value Ratio EMBC|TNDM - Market Capitalization to Book Value|Market Cap to Net Assets Ratio AxoGen, Inc.|SIBN - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio BVS|OrthoPediatrics (KIDS) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Treace Medical (TMCI)|Capitalization to Book Value Ratio Strata Medical (SRTA)|Carlsmed Inc (CARL) - Market Cap to Net Assets Ratio|Market Value to Book Value RXST (rxsight.com)|ClearPoint Neuro - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Stereotaxis Inc STXS|STIM (NeuroStar) - Market Capitalization to Book Value Ratio|SGHT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Orchestra BioMed|Anika Therapeutics, Inc. (ANIK) - Capitalization to Book Value Ratio|NSPR: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Jin Medical International Ltd|Market Capitalization to Book Value Ratio VANI (Vivani Medical, Inc.)|Market Cap to Net Assets Ratio xtantmedical.com (XTNT)|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Modular Medical Inc - Market Capitalization to Book Value Ratio|MYO - Market Value to Book Value Ratio|Envoy Medical Inc. (COCH) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Vivos Therapeutics, Inc VVOS|enVVeno Corp (NVNO) - Market Value to Book Value|Market Capitalization to Book Value Ratio SINT (Sintx Technologies Inc)|Market-to-Book Ratio TNON|LFWD: Market Value to Book Value Ratio|Market Value to Equity Ratio autonomix.com AMIX|Market Cap to Net Assets Ratio IVF (INVO Bioscience, Inc.)|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Market Capitalization to Book Value Ratio AXNX (Axonics, Inc.)|BIOL: Market Capitalization to Book Value|Market Value to Book Value Ratio dynatronics.com (DYNT)|FNA (Paragon 28) - Market Capitalization to Net Assets|Market Value to Book Value Ratio INVO